During the last session, Revelation Biosciences Inc (NASDAQ:REVB)’s traded shares were 0.14 million, with the beta value of the company hitting -0.09. The 52-week high for the REVB share is $60.80, that puts it down -7596.2 from that peak though still a striking 3.8% gain since the share price plummeted to a 52-week low of $0.76. The company’s market capitalization is $1.61M, and the average trade volume was 982.34K shares over the past three months.

Revelation Biosciences Inc (REVB) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. REVB has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -1.49.

Revelation Biosciences Inc (NASDAQ:REVB) trade information

Revelation Biosciences Inc (REVB) registered a 0.58% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.58% in intraday trading to $0.79, hitting a weekly high. The stock’s 5-day price performance is -4.37%, and it has moved by -74.69% in 30 days. Based on these gigs, the overall price performance for the year is -97.75%.

While earnings are projected to return 76.23% in 2025, the next five years will return 72.37% per annum.

REVB Dividends

Revelation Biosciences Inc is due to release its next quarterly earnings on 2025-May-08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.